Cas No.: | 1628732-62-6 |
Chemical Name: | (2R)-3,3,3-trifluoro-2-{[(5-fluoro-2-{1-[(2-fluorophenyl)methyl]- 5-(1,2-oxazol-3-yl)-1H-pyrazol- 3-yl}pyrimidin-4-yl)amino]methyl}-2-hydroxypropanamide |
Synonyms: | IW-1701;IW1701;IW 1701;IW1701 |
SMILES: | C(N)(=O)[C@](CNC1C(F)=CN=C(C2C=C(C3C=CON=3)N(CC3=CC=CC=C3F)N=2)N=1)(O)C(F)(F)F |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Publication: | [1]. Buys ES, et al. Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential. Nitric Oxide. 2018 Aug 1;78:72-80. |
Description: | Olinciguat (IW-1701) is an oral guanylate cyclase (sGC) stimulator with concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole cell assay[1]. |